🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

Recruitingn/aAges 18 Years - anyMaleVirdx, Inc.
NCT07432360 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In recent years, new and promising approaches have emerged in the field of MRI imaging of the prostate. These approaches usually aim to visualise the so-called "microstructures" of the tissue and are intended to offer greater accuracy in the diagnosis of prostate cancer than the current mpMRI examination. To this end, mathematical microstructure models are calculated that determine the proportional presence of histological substructures in specific MRI volumes. Additional new MRI sequences that are not routinely recorded are required to calculate the microstructure models. In order to further investigate the possibilities of these new MRI sequences, this study will compare different mathematical models. In addition, a histopathological examination of the tissue will be performed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Humans with a prostate ≥18 years of age. * Patients with biopsy-proven PCa who are scheduled for an RPE. * Signed informed consent form (ICF) that demonstrates study participant understands the purpose of and procedures necessary for the study. * Willingness, ability, and legal capacity to participate in the study. * Ability to adhere to the prohibitions and restrictions defined in this protocol. Exclusion Criteria: * Inability to give consent. * Prior hormone treatment (i.e., androgen deprivation treatment (ADT) and/or 5-ɑ-reductase inhibitors). * Prior PCa treatment. * Prior transurethral resection of the prostate (TUR-P) or other prostate surgery. * Prior total hip arthroplasty on one or both sides or other metal implants that interfere with the MRI acquisition of the hip region. * General contraindications for an MRI scan (i.e., pacemaker, relevant metal implants, etc.).
💊

What it tests

  • Not listed
📍

Where

1 site
Instituto do Câncer do Estado de São Paulo
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy